Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Quigley

Showing results (721-730 of 748) with videos related to

Pageof 75
Sort By:
American Journal of Human Genetics|June 13, 1998
DAX1 mutations map to putative structural domains in a deduced three-dimensional modelY H Zhang, W Guo, R L Wagner, et al.
JCI Insight|February 23, 2023
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancerErolcan Sayar, Radhika A Patel, Ilsa M Coleman, et al.
Molecular Oncology|February 22, 2025
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancerMarina N Sharifi, Eric Feng, Nicholas R Rydzewski, et al.
Investigative Ophthalmology & Visual Science|May 26, 2007
Heritable features of the optic disc: a novel twin method for determining genetic significanceAlex W Hewitt, Johan P Poulsen, Wallace L M Alward, et al.
Pharmaceutics|June 2, 2021
Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion CellsHenry T Hsueh, Yoo-Chun Kim, Ian Pitha, et al.
American Journal of Medical Genetics. Part A|April 30, 2015
Proceedings from the Turner Resource Network symposium: the crossroads of health care research and health care deliveryPhilippe F Backeljauw, Carolyn Bondy, Steven D Chernausek, et al.
European Urology|April 1, 2019
Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate CancerWilliam S Chen, Rahul Aggarwal, Li Zhang, et al.
Cancer Research|June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate CancerArian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Nature Communications|March 20, 2021
CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancerMusaddeque Ahmed, Fraser Soares, Ji-Han Xia, et al.
Nature Genetics|July 17, 2024
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancerShuang G Zhao, Matthew Bootsma, Stanley Zhou, et al.
Pageof 75

Showing results (721-730 of 748) with videos related to

Sort By:
Pageof 75
American Journal of Human Genetics|June 13, 1998
DAX1 mutations map to putative structural domains in a deduced three-dimensional modelY H Zhang, W Guo, R L Wagner, et al.
JCI Insight|February 23, 2023
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancerErolcan Sayar, Radhika A Patel, Ilsa M Coleman, et al.
Molecular Oncology|February 22, 2025
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancerMarina N Sharifi, Eric Feng, Nicholas R Rydzewski, et al.
Investigative Ophthalmology & Visual Science|May 26, 2007
Heritable features of the optic disc: a novel twin method for determining genetic significanceAlex W Hewitt, Johan P Poulsen, Wallace L M Alward, et al.
Pharmaceutics|June 2, 2021
Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion CellsHenry T Hsueh, Yoo-Chun Kim, Ian Pitha, et al.
American Journal of Medical Genetics. Part A|April 30, 2015
Proceedings from the Turner Resource Network symposium: the crossroads of health care research and health care deliveryPhilippe F Backeljauw, Carolyn Bondy, Steven D Chernausek, et al.
European Urology|April 1, 2019
Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate CancerWilliam S Chen, Rahul Aggarwal, Li Zhang, et al.
Cancer Research|June 8, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate CancerArian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Nature Communications|March 20, 2021
CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancerMusaddeque Ahmed, Fraser Soares, Ji-Han Xia, et al.
Nature Genetics|July 17, 2024
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancerShuang G Zhao, Matthew Bootsma, Stanley Zhou, et al.
Pageof 75